General Information of the Compound
Compound ID |
CP0372556
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl]-5-[2-[2-[2-[2-[[3-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylcarbamoyl]pyrazolo[1,5-a]pyridin-5-yl]methoxy]ethoxy]ethoxy]ethoxy]ethoxymethyl]pyrazolo[1,5-a]pyridine-3-carboxamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C54H72N10O9
|
||||||||||||||||||
Molecular Weight |
1005.231
|
||||||||||||||||||
Canonical SMILES |
COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCN6CCN(CC6)c6ccccc6OC)c5c4)cc23)CC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C54H72N10O9/c1-67-51-11-5-3-9-47(51)61-25-21-59(22-26-61)17-7-15-55-53(65)45-39-57-63-19-13-43(37-49(45)63)41-72-35-33-70-31-29-69-30-32-71-34-36-73-42-44-14-20-64-50(38-44)46(40-58-64)54(66)56-16-8-18-60-23-27-62(28-24-60)48-10-4-6-12-52(48)68-2/h3-6,9-14,19-20,37-40H,7-8,15-18,21-36,41-42H2,1-2H3,(H,55,65)(H,56,66)
Show/Hide
|
||||||||||||||||||
InChIKey |
YOPFVVBZYPEBHX-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Protein ID: PT01161, D(4) dopamine receptor